COMPASS PATHW SP.ADR (5Y6) - Total Liabilities

Latest as of December 2025: €263.20 Million EUR ≈ $307.70 Million USD

Based on the latest financial reports, COMPASS PATHW SP.ADR (5Y6) has total liabilities worth €263.20 Million EUR (≈ $307.70 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore COMPASS PATHW SP.ADR (5Y6) cash conversion ratio to assess how effectively this company generates cash.

COMPASS PATHW SP.ADR - Total Liabilities Trend (2021–2025)

This chart illustrates how COMPASS PATHW SP.ADR's total liabilities have evolved over time, based on quarterly financial data. See COMPASS PATHW SP.ADR net assets for net asset value and shareholders' equity analysis.

COMPASS PATHW SP.ADR Competitors by Total Liabilities

The table below lists competitors of COMPASS PATHW SP.ADR ranked by their total liabilities.

Company Country Total Liabilities
Shanghai Golden Bridge
SHG:603918
China CN¥319.78 Million
Korea Investment Holdings Co Ltd
KO:071055
Korea ₩124.06 Trillion
Gansu Golden Glass Technologies Co Ltd
SHE:300093
China CN¥4.08 Billion
Momentum Group AB (publ)
ST:MMGR-B
Sweden Skr1.58 Billion
SZZT Electronics Co Ltd
SHE:002197
China CN¥4.21 Billion
Tongyang Inc
KO:001525
Korea ₩616.60 Billion
Biotest Aktiengesellschaft
XETRA:BIO3
Germany €906.90 Million
ECOVE Environment Corp
TWO:6803
Taiwan NT$9.15 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down COMPASS PATHW SP.ADR's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see COMPASS PATHW SP.ADR stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.77 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -4.98 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.25 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how COMPASS PATHW SP.ADR's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for COMPASS PATHW SP.ADR (2021–2025)

The table below shows the annual total liabilities of COMPASS PATHW SP.ADR from 2021 to 2025.

Year Total Liabilities Change
2025-12-31 €263.20 Million
≈ $307.70 Million
+346.32%
2024-12-31 €58.97 Million
≈ $68.94 Million
+17.37%
2023-12-31 €50.24 Million
≈ $58.74 Million
+213.74%
2022-12-31 €16.01 Million
≈ $18.72 Million
-2.86%
2021-12-31 €16.49 Million
≈ $19.27 Million
--

About COMPASS PATHW SP.ADR

F:5Y6 Germany Medical Care Facilities
Market Cap
$841.91 Million
€720.13 Million EUR
Market Cap Rank
#11268 Global
#1267 in Germany
Share Price
€7.50
Change (1 day)
-3.23%
52-Week Range
€2.12 - €8.15
All Time High
€48.20
About

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as … Read more